Alliancebernstein L.P. Myriad Genetics Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 108,425 shares of MYGN stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,425

Previous 114,895 5.63%

Holding current value

$1.45 Million

Previous $2.81 Million 5.59%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.97 - $28.6 $155,085 - $185,042	-6,470 Reduced 5.63%	108,425 $2.97 Million
Q2 2024 Aug 14, 2024	BUY	$17.98 - $25.47 $24,902 - $35,275	1,385 Added 1.22%	114,895 $2.81 Million
Q1 2024 May 14, 2024	BUY	$17.59 - $23.59 $92,171 - $123,611	5,240 Added 4.84%	113,510 $2.42 Million
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $182,494 - $284,026	-11,959 Reduced 9.95%	108,270 $2.52 Million
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $26,553 - $38,411	1,830 Added 1.55%	120,229 $1.74 Million
Q3 2022 Nov 15, 2022	SELL	$18.21 - $27.88 $69,817 - $106,891	-3,834 Reduced 3.14%	118,399 $2.26 Million
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $68,464 - $107,712	4,162 Added 3.52%	122,233 $2.22 Million
Q1 2022 May 13, 2022	BUY	$22.67 - $28.01 $7,118 - $8,795	314 Added 0.27%	118,071 $2.98 Million
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $10,303 - $13,933	427 Added 0.36%	117,757 $3.25 Million
Q3 2021 Nov 10, 2021	SELL	$29.97 - $36.66 $115,983 - $141,874	-3,870 Reduced 3.19%	117,330 $3.79 Million
Q2 2021 Jul 30, 2021	BUY	$25.39 - $32.61 $164,273 - $210,986	6,470 Added 5.64%	121,200 $3.71 Million
Q1 2021 May 06, 2021	BUY	$19.92 - $31.6 $34,063 - $54,036	1,710 Added 1.51%	114,730 $3.49 Million
Q3 2020 Nov 12, 2020	BUY	$11.25 - $14.75 $1,912 - $2,507	170 Added 0.15%	113,020 $1.47 Million
Q2 2020 Aug 13, 2020	SELL	$10.69 - $16.49 $74,295 - $114,605	-6,950 Reduced 5.8%	112,850 $1.28 Million
Q1 2020 May 14, 2020	SELL	$9.78 - $29.53 $14,278 - $43,113	-1,460 Reduced 1.2%	119,800 $1.71 Million
Q4 2019 Feb 18, 2020	SELL	$20.93 - $35.1 $1.15 Million - $1.92 Million	-54,720 Reduced 31.09%	121,260 $3.3 Million
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $627,955 - $1.34 Million	-28,440 Reduced 13.91%	175,980 $5.04 Million
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $675,566 - $1.04 Million	29,800 Added 17.07%	204,420 $5.68 Million
Q1 2019 May 14, 2019	BUY	$26.93 - $34.7 $32,316 - $41,640	1,200 Added 0.69%	174,620 $5.8 Million
Q4 2018 Feb 13, 2019	SELL	$27.23 - $45.56 $170,160 - $284,704	-6,249 Reduced 3.48%	173,420 $5.04 Million
Q3 2018 Nov 08, 2018	SELL	$37.57 - $50.34 $413,608 - $554,193	-11,009 Reduced 5.77%	179,669 $8.27 Million
Q2 2018 Aug 13, 2018	BUY	$27.75 - $40.17 $650,959 - $942,307	23,458 Added 14.03%	190,678 $7.13 Million
Q1 2018 May 14, 2018	BUY	$28.83 - $41.01 $94,850 - $134,922	3,290 Added 2.01%	167,220 $4.94 Million
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $3.94 Million - $5.93 Million	163,930	163,930 $5.93 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Myriad Genetics Inc Transaction History